青少年银屑病生活质量量表的开发与初步验证
研究开发了首个针对12-17岁青少年银屑病的疾病特异性生活质量量表。通过定性访谈和认知访谈形成41条草稿,在50例独立样本中经项目缩减和Rasch模型构建出17条量表,含心理社会影响(12条)和躯体症状及治疗影响(5条)两个分量表。量表显示出可接受的重测信度和内部一致性,所有构念效度假设均得到支持。
要点
- 量表含17条,分心理社会影响和躯体症状及治疗影响两个分量表。
- 可用于日常临床和研究,支持以患者为中心的诊疗规划。
核心结论
- 青少年银屑病生活质量量表初步形式显示出有前景的心理测量学特性。
研究设计与样本
- 基于定性访谈和认知访谈开发条目,在50例青少年银屑病患者独立样本中采用经典测验理论和Rasch模型进行项目缩减与初步验证。
主要发现
- 定性数据来自18例青少年、14例家长和4名医疗专业人员,认知访谈测试12例,形成41条草稿。
- 最终量表17条,其中心理社会影响12条、躯体症状及治疗影响5条,两个分量表均良好拟合各自Rasch模型。
- 所有关于构念效度的先验假设均得到支持。
临床怎么用
- 该量表可用于日常临床实践和研究,支持以患者为中心的方法并辅助治疗规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No age-appropriate and disease-specific instrument currently exists to measure health-related quality of life in adolescents with psoriasis (patients aged 12-17 years). OBJECTIVES: To develop and provide preliminary validation of the Adolescent Psoriasis Quality of Life instrument. METHODS: Qualitative interviews with adolescents with psoriasis, parents of adolescents with psoriasis, and healthcare professionals informed the development of an initial item pool for the instrument, which was subsequently refined through cognitive interviews. Finally, data from an independent sample of adolescents with psoriasis (n = 50) were used for item reduction, scale construction and initial validation, using a combination of techniques from classical test theory and Rasch modelling. RESULTS: Rich qualitative data concerning health-related quality of life in adolescents with psoriasis (from 18 adolescents, 14 parents and four healthcare professionals), combined with cognitive interview testing (n = 12), resulted in a 41-item draft version. Item reduction led to the final version, a 17-item instrument consisting of two subscales showing good fit to their respective Rasch models: psychosocial impact (12 items) and the impact of physical symptoms and treatment (five items). All a priori stated hypotheses regarding construct validity were supported. Both subscales and the total scale showed acceptable test-retest reliabilities (intraclass correlations 0·97, 0·89 and 0·96) and internal consistencies (Cronbach's α 0·94, 0·81 and 0·95). CONCLUSIONS: The preliminary form of the Adolescent Psoriasis Quality of Life instrument shows promising psychometric properties. It can be used in daily clinical practice and research to support a patient-centred approach and inform treatment planning. What's already known about this topic? Health-related quality of life (HRQoL) instruments should be targeted towards narrowly defined age groups, as life contexts of children, adolescents and adults may differ substantially. Dermatology-specific instruments have been used to measure HRQoL in adolescents with psoriasis, but it is not known whether these instruments accurately capture all relevant HRQoL aspects in adolescent psoriasis. Age-appropriate and psoriasis-specific instruments may be more sensitive for HRQoL issues experienced by this unique group. What does this study add? The Adolescent Psoriasis Quality of Life instrument represents the first age-appropriate and disease-specific instrument for measuring HRQoL in adolescents (12-17 years old) with psoriasis. It is intended for use in daily clinical practice to support dermatologists and other healthcare professionals in providing optimal care for adolescents with psoriasis.
引用
- Randa H, Khoury LR, Grønborg TK, et al. Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument: a disease-specific measure of quality of life in adolescents with psoriasis. Br J Dermatol. 2020. PMID: 31743420. doi:10.1111/bjd.18719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。